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We identified a Bartonella quintana strain by poly-
merase chain reaction amplification, cloning, and sequenc-
ing of DNA extracted from lysed erythrocytes and cultured
colonies grown from peripheral blood collected from a cap-
tive-bred cynomolgus monkey (Macaca fascicularis). This
report describes naturally acquired B. quintana infection in
a nonhuman primate. 
B
artonella quintana, transmitted by the human body
louse (Pediculus humanis), is the etiologic agent for
trench fever. Although Mooser experimentally infected a
rhesus monkey with B. quintana >50 years ago, we report
the first naturally occurring infection with B. quintana in a
nonhuman primate (1).
A young adult female cynomolgus monkey (Macaca
fascicularis), born October 1, 1998, in a breeding facility
in Vietnam, was shipped on February 28, 2001, to Covance
Inc. (Alice, TX, USA), where she was quarantined and
acclimated by the vendor. On April 30, 2001, the monkey
was shipped to Laboratory Animal Services, Novartis
Pharmaceuticals Corporation (East Hanover, NJ, USA)
and held in quarantine until released on June 15, 2001, for
study and assigned an identification number of 1505.
Numerous procedures, treatments, and screening tests
were conducted by the vendor during the monkey’s quar-
antine in Texas and before its arrival in New Jersey. These
included the following: 1) vaccination against hepatitis A
(genus Hepatovirus) and measles (genus Morbillivirus); 2)
serologic testing for cytomegalovirus (subfamily
Betaherpesvirinae; positive), herpesvirus B (family
Herpesviridae, negative), simian type D virus (simian
retrovirus; SRV-1, -2, and -3; negative), simian immuno-
deficiency virus (SIV, genus Lentivirus; negative), simian
T-lymphotropic virus (STLV, genus BLV-HTLV retro-
viruses; negative); 3) testing by polymerase chain reaction
for SRV-1, -2, and -3 (negative); 4) Mantoux skin test for
Mycobacterium tuberculosis (negative ×4); and 5) treat-
ment for endoparasites with albendazole and avermectin,
for ectoparasites with insecticide dust, and for Plasmodium
spp. with chloroquine and primaquine. During the course
of routine microscopic review of no. 1505’s peripheral
blood collected pretest (July 9, 2001) and stained with
Wright stain (Hema-Tek 2000, Bayer Corporation, Wright
Stain Pak, Curtin Matheson Scientific Inc., Houston, TX,
USA), erythrocytic morphologic changes (moderate to
marked stomatocytosis, punctate discoloration, or poly-
chromatophilic aggregation) suggestive of a hemotropic
parasite were observed (Figure 1). Malarial parasites were
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Figure 1. Peripheral blood film, Wright stain, 1,000× (oil immer-
sion). A) Spherostomatocyte with suspect intracellular organism;
B) suspect membrane-associated organism; C) microcytes with
punctate discoloration; D) stomatocyte; E) poikilocyte with punc-
tate discoloration and suspected membrane-associated organism;
and F) aggregate of polychromatophilic erythrocytes and suspect
intracellular organism at tip of arrow. not observed.  At the resolution of light microscopy
(≈2 µm), basophilic particles were identified in association
with erythrocyte membranes, with less well-defined, pale-
blue inclusions seen within erythrocytes. Mean corpuscu-
lar volume was increased (82.2 fL). Blood from the same
K-EDTA collection tube was transferred to the Electron
Microscopy Laboratory (Novartis) for both transmission
electron microscopy (TEM) and scanning electron
microscopy (SEM) evaluation. Although intra- and extra-
erythrocytic bacterial organisms were confirmed by TEM,
and SEM identified numerous pits, the morphologic char-
acteristics were not unique identifiers for Bartonella spp.
(Figure 2). Since the sample was discarded after aliquots
were taken for electron microscopy, a new K-EDTA blood
sample was collected for culture from monkey no. 1505
and sent on ice by overnight delivery to the Intracellular
Pathogens Laboratory, North Carolina State University
College of Veterinary Medicine. Clinical observations dur-
ing the study dosing period were unremarkable, and no
unusual lesions were observed at necropsy or during histo-
logic examination of selected tissues. 
The Study
Approximately 1.5 mL K-EDTA blood received from
Novartis was frozen (–80°C) and then thawed 1 week later
after lysis of the erythrocytes. After centrifugation of the
sample at 3,000 × g for 30 min, the pellet was resuspend-
ed in M199 (Cellgro, Mediatech, Inc., Herndon, VA, USA)
containing 20% (vol/vol) fetal bovine serum, 22.5%
(vol/vol) sodium bicarbonate, 100 mmol/L sodium pyru-
vate and GlutaMAX-1 (Gibco Life Technologies, Grand
Island, NY, USA) and spread onto trypticase soy agar con-
taining 5% (vol/vol) rabbit blood and chocolate agar
(Becton Dickinson, Cockeysville, MD, USA), respective-
ly. Plates were incubated at 35°C under 5% CO2 and mon-
itored for up to 6 weeks.
Five hundred microliters phosphate-buffered saline
(PBS) was added to 200 µL blood (previously frozen at
–80°C) and centrifuged at 20,817 × g for 6 min. The super-
natant was removed, and the pellets were resuspended in
500 µL1× PBS followed by centrifugation for 6 min. After
removing the supernatant, and resuspending the samples in
200 µLPBS, we extracted DNAby using a QIAamp Blood
Kit (Qiagen, Chatsworth, CA, USA) DNA from culture-
grown B. henselae strain Houston-1, B. vinsonii subspecies
berkhoffii  (93CO-1),  B. elizabethae,  B. clarridgeiae
(NCSU 94-F40), and B. quintana (ATCC VR-358) were
used for all PCRs as control templates. 
Amplification of the 16S rDNAand the 16S–23S inter-
genic spacer (ITS) regions was performed as described
earlier (2,3). Amplification conditions for the citrate syn-
thase gene (gltA) were the same as for the 16S–23S ITS
region except that primers BhCS 1137n1 (5′ AATG-
CAAAAAGA ACAGTAAACA 3′) and CS443f 2 (5′
GCTATGTCTGCATTCTATCA 3′) were used (4).
Selective PCR amplifications for the 16S rDNA, 23S
rDNA, and rnpB were performed as described (2). 
After cloning, recombinant plasmid DNA for gltA and
the 16S–23S ITS region was sequenced bidirectionally
with the infrared fluorescently labeled primers
M13Reverse (5′ CAGGAAACAGCTATGACCATG) and
T7 (5′ TAATACGACTCACTATAGGGCGA). The recom-
binant DNAcarrying the genes for 23S rDNA, 16S rDNA,
and rnpB was sequenced as described elsewhere (5). All
sequences were aligned by using the multiple sequence
alignment editor ALIGN-IR (LI-COR), and consensus
sequences for every gene sequenced were determined.
Consensus sequences were then used to identify the clos-
est match within GenBank. To determine the exact phylo-
genetic relationship of the new isolate within the genus
Bartonella, we analyzed an alignment that contained the
sequences of 3 important phylogenetic markers, ribonucle-
ase P RNA (RNase P RNA), 16S rDNA, and 23S rDNA,
merged by catenation and organized by secondary struc-
ture elements, as described (5). Our dataset comprises 14
Bartonella strains (Table), including the 7 strains known to
be human pathogens. We have also used the sequence
information for the gltA as well as the 16S–23S rDNAITS
for sequence similarity analysis. Sequences have been
deposited in GenBank with accession numbers AY484592
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Figure 2. A) Electron microscopy scan
of peripheral blood. B) Transmission
electron microscopy scan of peripheral
blood. a, membrane invaginations; b,
stomatocytes and spherostomatocytes;
c, erythrocyte with vacuole-enclosed
suspect organism.(16S rDNA), AY484593 (23S rDNA), AY484594 (RNase
P RNA), and AY484595 (gltA).
On day 14 after blood plating, growth typical for mem-
bers of the genus Bartonella was obtained. Sixty-two small
to medium-sized, white, shiny, smooth, nonadherent
colonies were detected on chocolate agar. By day 16 after
plating, 43 colonies of similar appearance were evident on
blood agar. The strain was designated Bartonella strain
CMO-01-1.
DNA could be successfully extracted, and subsequent
PCR reactions resulted in PCR products representing 23S
rRNA, 16S rRNA, RNase P RNA, 16S-23S rDNA ITS
sequence, and the citrate synthase gene. All products were
successfully cloned and sequenced. Sequencing of multi-
ple clones for each gene resulted in sequences that were
>99% identical to existing sequences derived from B.
quintana, with the exception of the 16S–23S rDNA ITS
sequence (>98.4%) and gltA (98%). Initial BLAST search
results showed that the sequences for the 23S rDNA, the
16S rDNA, RNase P RNA, 16S–23S rDNA ITS sequence,
and gltA derived from strain CMO-01-1 best matched B.
quintana sequences that have been reported to GenBank.
The data could be reproduced by using DNA extracted
from the K-EDTA blood sample or from pure colonies
grown on both chocolate and blood agar. 
Subsequent comprehensive phylogenetic analysis
clearly identified the isolate CMO-01-1 as a close relative
of B. quintana type strain “Fuller.” The statistical support
for this relationship is 100%, as indicated by the bootstrap
values for the phylogenetic tree (Figure 3). 
Conclusions
Our findings support the close relationship of B. quin-
tana and the new cynomolgus monkey isolate. The evolu-
tionary distance (Figure 3) between B. quintana and the
new isolate is similar to the evolutionary distance between
the 3 subspecies of B. vinsonii. The high degree of
sequence identity for the 16S rDNA of our isolate to other
B. quintana 16S rDNA sequences deposited in GenBank
clearly identifies strain CMO-01-1 as B. quintana.
However, the high degree of 16S rDNA sequence identity
makes a discriminatory match within or below the species
level impossible. We have therefore applied the combined
use of the phylogenetic markers RNase P RNA, 16S
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Figure 3. Phylogenetic tree of Bartonella species (Table) based on
the combined RNase P RNA, 16S, and 23S rRNA sequence align-
ment. Agrobacterium tumefaciens serves as the outgroup in this
tree. The tree shown was generated by using the neighbor-joining
method. The horizontal axis is estimated evolutionary distance.
The numbers shown at each node are the number of times that
node appears among 1,000 bootstrapped trees. T, type strains.
Bartonella quintana in Cynomolgus MonkeyDISPATCHES
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rRNA, and 23S rRNA for a comprehensive phylogenetic
analysis. The advantage of such an analysis within the
genus Bartonella has been discussed by Pitulle et al. (2).
We have used the same dataset (Table) as described earli-
er (2) but added the sequences derived from the isolate
CMO-01-1. We therefore consider the new isolate a novel
strain of B. quintana.
The 1.6% sequence dissimilarities of the 16S–23S
rDNA ITS data derived from CMO-01-1 to published
16S–23S rDNA ITS sequences for B. quintana are phylo-
genetically insignificant. The 16S–23S rDNA ITS region
is a highly sequence variable area within the bacterial
genome that can differ to the extent seen in our study at or
below the species level (3,5). The sequences determined in
our study have the same length as the 16S–23S rDNA ITS
sequence reported for B. quintana, which further supports
our conclusion that CMO-01-1 is a strain of B. quintana.
The  gltA sequence derived from the bacterial strain
CMO-01-1 is 98% identical to that derived from B. quin-
tana. This match was the highest within the genus
Bartonella. The next closest match was B. henselae with
92% similarity. This degree of sequence identity also sug-
gests that CMO-01-1 represents a strain of B. quintana. 
Confinement practices used for monkey 1505 should
have eliminated or substantially restricted possible expo-
sure to insect vectors, such as the human body louse
(Pediculus humanis). Neither an exposure date nor an
arthropod vector was identified in this monkey. Chronic
subclinical infection with B. quintana has been docu-
mented following experimental infection of monkeys (1)
and in humans for B. quintana (5,6) and B. bacilliformis
(7). Persistent infection was suspected but was not docu-
mented in this monkey because of the delay in bacterial
identification. Bred and raised in outdoor facilities located
in Southeast Asia, these primates often arrive in the United
States with subclinical malaria, proof that exposure to
mosquitoes and potentially other insects has occurred. B.
quintana DNA has been recently found in ticks and fleas
(8,9).
The reemergence of B. quintana infections in humans
has expanded awareness of the organism’s ability to induce
persistent bacteremia in people with few symptoms
(5,6,10,11). Because of the small number of infected ery-
throcytes needed to sustain infection, screening peripheral
blood for organisms, even with confocal microscopy, has a
poor success rate (12). Our findings indicate that nonhu-
man primates may serve as a previously unrecognized
reservoir for human B. quintana infection. 
Dr O’Rourke is a veterinary clinical pathologist at the
University College Dublin, Dublin, Ireland.
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